Evaluation of gadobenate dimeglumine for contrast-enhanced MRI of the breast.
Hylton
Nola M
NM
Department of Radiology, Magnetic Resonance Science Center, University of California, San Francisco, AC-109, 1 Irving St., San Francisco, CA 94143-1290, USA.
D001943:Breast Neoplasms / Q000473:pathology*; D017322:Clinical Trials, Phase II as Topic; D003287:Contrast Media / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D019786:Gadolinium DTPA / Q000008:administration & dosage*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008536:Meglumine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D015337:Multicenter Studies as Topic; D009942:Organometallic Compounds / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D003287:Contrast Media; D009942:Organometallic Compounds; C064572:gadobenic acid; D008536:Meglumine; D019786:Gadolinium DTPA